New push for more NIH funds

Following President Bush's linkurl:veto;http://www.the-scientist.com/news/display/53858/ of a spending bill that included linkurl:$30 billion;http://www.the-scientist.com/blog/display/53852 for the National Institutes of Health, Congress continues to work on revised appropriations levels for fiscal year 08, which began two months ago. With a temporary funding resolution running out next week and the holiday break looming ahead, lawmakers are pushing to get a bill to the President next week. A r

kerry grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Following President Bush's linkurl:veto;http://www.the-scientist.com/news/display/53858/ of a spending bill that included linkurl:$30 billion;http://www.the-scientist.com/blog/display/53852 for the National Institutes of Health, Congress continues to work on revised appropriations levels for fiscal year 08, which began two months ago. With a temporary funding resolution running out next week and the holiday break looming ahead, lawmakers are pushing to get a bill to the President next week. A resolution by Congress allows agencies to operate at 2007 levels for now, but the resolution lasts only until December 14. What happens next to funding levels is "the big unknown," Kei Koizumi, the director of R&D budget and policy program at the American Association for the Advancement of Science, told __The Scientist__. The options include extending the resolution. The problem, Koizumi said, "is that for any agency it is really hard to plan for a new year's program on last year's budget." Additionally, continuing 2007 linkurl:funding levels;http://www.the-scientist.com/news/display/53580 delays increases that some agencies might see. Stacie Propst, the senior director of policy and outreach at Research!America (a group whose board of directors includes __The Scientist's__ founder, Eugene Garfield), told __The Scientist__ her group is urging lawmakers to write in a 3.1% increase in the NIH budget and a 6.6% increase in the Centers for Disease Control and Prevention budget. Koizumi said Congressional leadership set a Monday (December 10) deadline for committees to have their appropriations ready. Whether the NIH or CDC will get any increases in unknown, although Karl Moeller, the executive director of the Campaign for Public Health, told __The Scientist__ that if Congress went with the President's budget request from February, the CDC would see a cut to its budget. "That's the worst case scenario," Moeller said.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
A greyscale image of cells dividing.
March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue
Discover the history, mechanics, and potential of PCR.

Become a PCR Pro

Integra Logo
Explore polypharmacology’s beneficial role in target-based drug discovery

Embracing Polypharmacology for Multipurpose Drug Targeting

Fortis Life Sciences
3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Thermo Fisher Logo
A photo of sample storage boxes in an ultra-low temperature freezer.

Navigating Cold Storage Solutions

PHCbi logo 

Products

The Scientist Placeholder Image

Gilead’s Capsid Revolution Meets Our Capsid Solutions: Sino Biological – Engineering the Tools to Outsmart HIV

Stirling Ultracold

Meet the Upright ULT Built for Faster Recovery - Stirling VAULT100™

Stirling Ultracold logo
Chemidoc

ChemiDoc Go Imaging System ​

Bio-Rad
The Scientist Placeholder Image

Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb